J Korean Androl Soc.  1993 Dec;11(2):121-124.

Effect Of Alpha: Adrenergic Blocker In Thermoresistant Benign Prostatic Hyperplasia

Affiliations
  • 1Department of Urology, Yonsei University College of Medicine, Seoul, Korea.

Abstract

After thermotherapy in 100 patients with benign prostatic hyperplasia(BPH), the overall improvement rate-defined as more than 50% subjective or objective improvement-was 64%, but both subjective and objective symptom improvement were seen in only 26%. We evaluated the effectiveness of an alpha-adrenergic blocker in the 57 patients with thermoresistant BPH(i.e., those who did not have a complete response), beginning at least 1 month after thermotherapy. After at least 1 month of treatment, the overall improvement rate was 47%(27/50). Therefore, the combined improvement rate of thermotherapy plus an alpha-adrenergic blocker in the 83 patients available for follow-up was 87%. We conclude that the use of an alpha-adrenergic blocker in patients with thermoresistant BPH increases their chance of avoiding operation.


MeSH Terms

Adrenergic Antagonists*
Follow-Up Studies
Humans
Hyperthermia, Induced
Prostatic Hyperplasia*
Adrenergic Antagonists
Full Text Links
  • JKAS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr